Cello Therapeutics
PrivateLast Round
Series A
Extension
Aug 8, 2022
Total Funding Raised
$8.65M
Company Overview
Cello Therapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A Extension round in August 2022.
Cello Therapeutics is a biotechnology company that develops novel nanoparticle delivery platforms for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cello Therapeutics Comparables
Compare Cello Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coastar Therapeutics | 89% | |
| Duo Oncology | 82% | |
| Pendrea Bio, Inc. | 77% |
For institutional investors. Book with your work email.
Cello Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 8, 2022 | ||||
| Debt | May 3, 2020 | ||||
| Series A | Jun 8, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 1952% MoM, from 46 to 944.
- Jan 2, 2026
Monthly visitors increased 1470% MoM, from 46 to 722.
For institutional investors. Book with your work email.
Cello Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cello Therapeutics's valuation, stock price, and market status.
Is Cello Therapeutics a public or private company?
Cello Therapeutics is a private company.
What is the current stock price of Cello Therapeutics?
Cello Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cello Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cello Therapeutics worth (valuation)?
Valuation information for Cello Therapeutics is not publicly available.
Can I buy Cello Therapeutics stock?
Cello Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cello Therapeutics's last funding round?
Cello Therapeutics's most recent funding round was Series A Extension on August 8, 2022.
Who are the main investors in Cello Therapeutics?
Investor information for Cello Therapeutics is not publicly disclosed.
Will Cello Therapeutics IPO soon?
No public IPO plans have been announced for Cello Therapeutics.
How can I track Cello Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cello Therapeutics's shares on secondary markets.